Nuvilex, Inc.'s Phase III Pancreatic Cancer Trials Could Address New Law's Call for Progress NEW YORK, NY--(Marketwired - Jun 24, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a great opportunity to demonstrate and showcase its encapsulation technology in its upcoming Phase III clinical trials...